Analysis of the GSE118985 dataset (n = 460 newly diagnosed MM patients) revealed that bone marrow biopsies with high ERRγ expression exhibited elevated RANKL (pro-osteoclastogenic factor) and reduced OPG (osteoclastogenesis inhibitor) levels. The gene discussed is ESRRG; the disease is Miyoshi myopathy.